The global tissue diagnostic market is expected to reach USD 5.02 Billion by 2027, according to a new report by Reports and Data. Tissue diagnostics is the process of removing the tissues and staining it for the diagnosis of diseases, particularly cancer. Recently, there have been novel technological advancements in the network-based medicine, which allows for detection, visualization, and monitoring of conditions in a more effective way, which would result in better treatment of the diseases.
COVID-19 Impact
As the global economies are experiencing the negative impact of the Covid-19 pandemic, organizations are suffering losses, among various other challenges. Nevertheless, firms in the pharmaceutical industry are of immense importance in combatting the pandemic and are witnessing positive growth in the contagious disease landscape with the race for treatment approval therapy gaining momentum. Tissue diagnostics finds usage in detecting the presence of SARS-CoV-2 in the tissues of patients and hence is garnering significant momentum in the market.
Get a Free Sample now@ https://www.reportsanddata.com/sample-enquiry-form/3411
Further key findings from the report suggest
- By type, diagnostics kits held a substantial market share in 2019, owing to the offering of ease and convenience of use. There are various diagnostic kits available in the market, some of which provide an instant result, whereas others as collection devices for tissue specimens, which need to be sent to laboratories for further processing.
- By technology, in situ hybridization held the second-largest market share in 2019. There are many advantages of in situ hybridization comprising the application to frozen tissues, as well as its usage in combination with immunohistochemistry for the identification protein, along with mRNA.
- By application, prostate cancer is likely to grow at a rate of 5.9% in the forecast period. According to the American Cancer Society, men aged 65 years or older have around 66.0% higher risk of suffering from the disease. Also, prostate cancer holds the second spot among the cancer diseases responsible for the death of men in America.
- By end-user, the pharmaceutical organization is likely to grow at a rate of 6.5% in the forecast period 2019, owing to an extensive application of tissue diagnostic in the process of drug development and several other analytical procedures.
- The market in the Asia Pacific region is expected to grow at the fastest rate of 7.3% in the forecast period. The high growth of the APAC region is owing to the growing prevalence of target conditions, growth of the pharmaceutical industry, and a surge in R&D activities the diagnostic procedures, among others.
- Key participants include Thermo Fisher Scientific, Danaher, Becton, Dickinson, and Company, Agilent Technologies, Abbott, Roche, Merck KGaA, Biogenex, Hologic Inc., and Abcam, among others.
- In May 2020, Agilent Technologies Inc. Visiopharm made an announcement about the signing of a co-agreement for end-to-end standardization and quality of tissue diagnostics and cater to the growing requirements of pathology labs globally.
Ask for discount@ https://www.reportsanddata.com/discount-enquiry-form/3411
For the purpose of this report, Reports and Data have segmented the global tissue diagnostics market on the basis of type, technology, application, end-user, and region:
Type Outlook (Revenue, USD Million; 2017-2027)
- Diagnostic Kits
- Antibodies
- Slide Training System
- Tissue Processing System
Technology Outlook (Revenue, USD Million; 2017-2027)
- Immunohistochemistry
- In Situ Hybridization
- Digital Pathology & Workflow
- Primary & Special Training
- Anatomic Pathology
Application Outlook (Revenue, USD Million; 2017-2027)
- Breast Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Lung Cancer
- Others
End-User Outlook (Revenue, USD Million; 2017-2027)
- Hospitals
- Research Laboratories
- Pharmaceutical Organizations
- Contract Research Organizations
Regional Outlook (Revenue, USD Million; 2017-2027)
- North America
- Europe
- Germany
- UK
- France
- Benelux
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- MEA
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
Why should buy this report?
- Provides in depth research analysis of the overall Tissue Diagnostics market. Which can help save time for start-up businesses related to the Tissue Diagnostics Market.
- The Tissue Diagnostics markets latest news, forecast analysis as well as the key competitors of the market are easily available with all the necessary information.
- The Tissue Diagnostics report comprises of graphs, pie charts and other representations that can help the reader understand the information at a glance.
- Through the Tissue Diagnostics report the manufacturers can understand the consumer behavior, business segments as well as sell products-based information provided.
- COVID-19 impact on the market and industry as well as the recovery analysis.
To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/tissue-diagnostics-market
Thank you for reading our report. To know more about the customization of the report or further query about the report, please get in touch with us. Our team will ensure the report is well suited to your requirements. |